BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Sequiam Corporation Announces New Client Relationship With The University of Mississippi Medical Center


10/19/2005 5:12:16 PM

ORLANDO, Fla., Nov. 22 /PRNewswire-FirstCall/ -- Sequiam Corporation (BULLETIN BOARD: SQUM) , through its wholly owned subsidiary Sequiam Software Inc (http://www.sequiamsoftware.com/), a leading information management and software technology company specializing in Web-based application services for enterprises, print service providers and the education and travel industries, today announced that it will be providing, through its authorized channel partner Danka Inc, Sequiam's SmartAccess 123 print management solution to the University of Mississippi Medical Center in Jackson, Mississippi. This solution will work in conjunction with Danka's printing solutions to enhance performance of the medical center's print shop.

Combining Sequiam's Print It, 123! and Scan It, 123!, SmartAccess 123 will give the Medical Center's users the ability to print to the in-plant print shop as easily as printing to a local or workgroup printer by simply selecting the print shop as a printer from within the application. Access to any industry-standard scanner allows users to just as easily manage the printing of paper-based documents.

"We are pleased to be working with the University of Mississippi Medical Center, one of the nation's most prestigious university medical centers," said David Dobkin, President of Sequiam Software, a division of Sequiam Corporation. "We expect our collaborative efforts with Danka to quickly deliver measurable results for the University of Mississippi Medical Center as we complete installation."

With no up-front capital investment required, SmartAccess 123 is a cost-effective and risk-free option for managing print within the university campus environment in a time where university operating budgets are increasingly constrained. Through its arrangement with Danka, the University of Mississippi Medical Center has agreed to process an initial 20 million pages of capacity through the Sequiam system.

About Sequiam

Founded in 1999, Sequiam Corporation develops, markets, and supports a portfolio of proprietary security, biometric, Internet and print enterprise-class software and hardware products that enable users to secure, acquire, manage, personalize, and present information. Sequiam provides application service provider ("ASP") hosting of its Internet-enabled solutions, as well as consulting, application integration, and custom Web development and software development services. Sequiam's hosting facility located in Orlando FL provides processing, print, mail, archival, and Internet delivery of documents as an outsourced service.

SAFE HARBOR STATEMENT -- FORWARD LOOKING STATEMENTS

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the company and its subsidiaries. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by the company may differ materially from these statements due to a number of factors. Any forward-looking statements speak only as of the date made. Statements made in this document that are not purely historical are forward-looking statements, including any statements as to beliefs, plans, expectations, or intentions regarding the future. Risk factors that may cause results to differ from projections include, without limitation, loss of suppliers, loss of customers, inadequate capital, competition, loss of key executives, declining prices, and other economic factors. The company assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. You should independently investigate and fully understand all risks before making investment decisions.

For more information, please contact: investors, Michael Mason, michaelm@allencaron.com, or Brian Kennedy, brian@allencaron.com, both of Allen & Caron Inc, +1-212-691-8087, for Sequiam Corporation; or Nick VandenBrekel, CEO of Sequiam Corporation, +1-407-541-0773, investor@sequiam.com.

Sequiam Corporation

CONTACT: investors, Michael Mason, michaelm@allencaron.com, or BrianKennedy, brian@allencaron.com, both of Allen & Caron Inc, +1-212-691-8087, forSequiam Corporation; or Nick VandenBrekel, CEO of Sequiam Corporation,+1-407-541-0773, investor@sequiam.com


Read at BioSpace.com

Related News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->